Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 136

1.

Host envelope glycoprotein processing proteases are indispensable for entry into human cells by seasonal and highly pathogenic avian influenza viruses.

Kido H, Okumura Y, Takahashi E, Pan HY, Wang S, Chida J, Le TQ, Yano M.

J Mol Genet Med. 2008 Nov 29;3(1):167-75.

2.

Novel type II transmembrane serine proteases, MSPL and TMPRSS13, Proteolytically activate membrane fusion activity of the hemagglutinin of highly pathogenic avian influenza viruses and induce their multicycle replication.

Okumura Y, Takahashi E, Yano M, Ohuchi M, Daidoji T, Nakaya T, Böttcher E, Garten W, Klenk HD, Kido H.

J Virol. 2010 May;84(10):5089-96. doi: 10.1128/JVI.02605-09. Epub 2010 Mar 10.

3.

Role of host cellular proteases in the pathogenesis of influenza and influenza-induced multiple organ failure.

Kido H, Okumura Y, Takahashi E, Pan HY, Wang S, Yao D, Yao M, Chida J, Yano M.

Biochim Biophys Acta. 2012 Jan;1824(1):186-94. doi: 10.1016/j.bbapap.2011.07.001. Epub 2011 Jul 23. Review.

4.

Influenza virus activating host proteases: Identification, localization and inhibitors as potential therapeutics.

Garten W, Braden C, Arendt A, Peitsch C, Baron J, Lu Y, Pawletko K, Hardes K, Steinmetzer T, Böttcher-Friebertshäuser E.

Eur J Cell Biol. 2015 Jul-Sep;94(7-9):375-83. doi: 10.1016/j.ejcb.2015.05.013. Epub 2015 Jun 1.

PMID:
26095298
5.

Role of host trypsin-type serine proteases and influenza virus-cytokine-trypsin cycle in influenza viral pathogenesis. Pathogenesis-based therapeutic options.

Kido H, Takahashi E, Kimoto T.

Biochimie. 2019 Sep 10. pii: S0300-9084(19)30264-0. doi: 10.1016/j.biochi.2019.09.006. [Epub ahead of print] Review.

PMID:
31518617
6.

Proteases essential for human influenza virus entry into cells and their inhibitors as potential therapeutic agents.

Kido H, Okumura Y, Yamada H, Le TQ, Yano M.

Curr Pharm Des. 2007;13(4):405-14. Review.

PMID:
17311557
7.

TMPRSS2 is the major activating protease of influenza A virus in primary human airway cells and influenza B virus in human type II pneumocytes.

Limburg H, Harbig A, Bestle D, Stein DA, Moulton HM, Jaeger J, Janga H, Hardes K, Koepke J, Schulte L, Koczulla AR, Schmeck B, Klenk HD, Böttcher-Friebertshäuser E.

J Virol. 2019 Aug 7. pii: JVI.00649-19. doi: 10.1128/JVI.00649-19. [Epub ahead of print]

PMID:
31391268
9.

[Host cellular proteases trigger the infectivity of the influenza virus in the airway and brain].

Kido H, Chen Y, Yamada H, Okumura Y.

Nihon Yakurigaku Zasshi. 2003 Jul;122(1):45-53. Review. Japanese.

PMID:
12843572
10.

Infection of Mouse Macrophages by Seasonal Influenza Viruses Can Be Restricted at the Level of Virus Entry and at a Late Stage in the Virus Life Cycle.

Londrigan SL, Short KR, Ma J, Gillespie L, Rockman SP, Brooks AG, Reading PC.

J Virol. 2015 Dec;89(24):12319-29. doi: 10.1128/JVI.01455-15. Epub 2015 Sep 30.

11.

The host protease TMPRSS2 plays a major role in in vivo replication of emerging H7N9 and seasonal influenza viruses.

Sakai K, Ami Y, Tahara M, Kubota T, Anraku M, Abe M, Nakajima N, Sekizuka T, Shirato K, Suzaki Y, Ainai A, Nakatsu Y, Kanou K, Nakamura K, Suzuki T, Komase K, Nobusawa E, Maenaka K, Kuroda M, Hasegawa H, Kawaoka Y, Tashiro M, Takeda M.

J Virol. 2014 May;88(10):5608-16. doi: 10.1128/JVI.03677-13. Epub 2014 Mar 5.

12.

Kallikrein-Related Peptidase 5 Contributes to H3N2 Influenza Virus Infection in Human Lungs.

Magnen M, Gueugnon F, Guillon A, Baranek T, Thibault VC, Petit-Courty A, de Veer SJ, Harris J, Humbles AA, Si-Tahar M, Courty Y.

J Virol. 2017 Jul 27;91(16). pii: e00421-17. doi: 10.1128/JVI.00421-17. Print 2017 Aug 15.

14.

Novel insights into proteolytic cleavage of influenza virus hemagglutinin.

Bertram S, Glowacka I, Steffen I, Kühl A, Pöhlmann S.

Rev Med Virol. 2010 Sep;20(5):298-310. doi: 10.1002/rmv.657. Review.

PMID:
20629046
16.

Up-regulation of ectopic trypsins in the myocardium by influenza A virus infection triggers acute myocarditis.

Pan HY, Yamada H, Chida J, Wang S, Yano M, Yao M, Zhu J, Kido H.

Cardiovasc Res. 2011 Feb 15;89(3):595-603. doi: 10.1093/cvr/cvq358. Epub 2010 Nov 16.

17.

Cellular proteinases trigger the infectivity of the influenza A and Sendai viruses.

Kido H, Murakami M, Oba K, Chen Y, Towatari T.

Mol Cells. 1999 Jun 30;9(3):235-44. Review.

18.

A peptide-based approach to evaluate the adaptability of influenza A virus to humans based on its hemagglutinin proteolytic cleavage site.

Straus MR, Whittaker GR.

PLoS One. 2017 Mar 30;12(3):e0174827. doi: 10.1371/journal.pone.0174827. eCollection 2017.

19.

Influenza HA subtypes demonstrate divergent phenotypes for cleavage activation and pH of fusion: implications for host range and adaptation.

Galloway SE, Reed ML, Russell CJ, Steinhauer DA.

PLoS Pathog. 2013 Feb;9(2):e1003151. doi: 10.1371/journal.ppat.1003151. Epub 2013 Feb 14.

20.

The role of fusion activity of influenza A viruses in their biological properties.

Jakubcová L, Hollý J, Varečková E.

Acta Virol. 2016 Jun;60(2):121-35. Review.

PMID:
27265461

Supplemental Content

Support Center